Terapia Génica del Cáncer
TGC
Royal Perth Hospital
Perth, AustraliaPublicaciones en colaboración con investigadores/as de Royal Perth Hospital (1)
2016
-
SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (Plus or Minus Bevacizumab) versus mFOLFOX6 (Plus or Minus Bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer
Journal of Clinical Oncology, Vol. 34, Núm. 15, pp. 1723-1731